Updated on 26.12.2025 @ 13:33 PM
The issue withdrawn due to low subscription.
Phytochem Remedies (India) Limited (PRIL) is launching its IPO on BSE SME. The issue will be open from 18th Dec 2025, and it will close on 22nd december 2025. You can track other upcoming and live IPOs at our IPO calendar.
With a price set at ₹98 per share and a goal to raise over ₹38 crores, PRIL aims to expand its manufacturing of corrugated boxes and enter new sustainable packaging segments.
If you are also building long-term wealth beyond IPO participation, you may explore our Mutual Fund Hub, which offers guides, comparisons, and learning resources across mutual funds. Additionally, our SIP Calculator can help estimate potential wealth creation through systematic investments over time.
In this article, you will find Phytochem Remedies IPO GMP today, subscription status, allotment date, price band, and a detailed review.
Phytochem Remedies IPO Details:
- Price Band: ₹98 per share (Fixed Price)
- IPO Open / Close Dates: December 18, 2025 – December 22, 2025
- Lot Size: 1,200 Shares (Note: Retail Minimum Application is 2 Lots / 2,400 Shares)
- Issue Size: 39,00,000 Equity Shares / ₹38.22 Crores
- Fresh Issue / OFS: 100% Fresh Issue
- Registrar: Bigshare Services Pvt.Ltd.
- Listing Exchange: BSE SME
WHAT IS THE Phytochem Remedies IPO GMP Today?
You can check the GMP of this and other issues at our GMP hub page.
Note: The Grey Market Premium (GMP) changes daily based on market demand. It is an unofficial indicator and is not regularised by SEBI, NSE, or BSE. Investors should not rely solely on GMP for investment decisions.
Listing Updates:
The issue is not listed. It is withdrawn due to under subscription. Till the last day, the issue got only 62% subscription with only 797 applications.
What Are The Important Phytochem Remedies IPO Dates & Allotment Schedule?
For investors tracking the timeline, here is the schedule to keep handy:
- IPO Open Date: Thursday, December 18, 2025
- IPO Close Date: Monday, December 22, 2025
- Basis of Allotment Date: Tuesday, December 23, 2025
- Refund Initiation Date: Wednesday, December 24, 2025
- Credit of Shares: Wednesday, December 24, 2025
- Listing Date: Friday, December 26, 2025
What Are The Objectives of Phytochem Remedies IPO?
The company intends to utilise the net proceeds from the fresh issue for the following strategic purposes:
- Debt Repayment: A significant portion (₹9.37 Crores) will go towards repaying existing borrowings to improve the debt-to-equity ratio.
- Capital Expenditure: Approximately ₹13.60 Crores is earmarked for purchasing new machinery and civil construction to diversify into paper bags and specialty coatings.
- Towards Civil Construction: 5.88 Crores will go to funding capital expenditure requirements towards civil construction
- General Corporate Purposes: To meet ongoing operational contingencies.
How is The Financial Performance of Phytochem Remedies?
The following table summarises the company's financial health.
In ₹ Crores
| Period Ended | 30 Sep 2025 (6 Months) | 31 Mar 2025 (FY25) | 31 Mar 2024 (FY24) | 31 Mar 2023 (FY23) |
Total Income | 25.01 | 36.81 | 32.89 | 20.82 |
Profit After Tax | 3.75 | 4.48 | 2.31 | 0.82 |
EBITDA | 6.72 | 8.69 | 5.88 | 2.91 |
Net Worth | 16.89 | 13.14 | 8.74 | 6.42 |
Total Borrowing | 19.32 | 18.68 | 21.02 | 20.30 |
Assets | 53.68 | 44.50 | 41.85 | 37.07 |
Source: RHP
Observations and Analysis:
Total Income:
The company has shown robust top-line growth with a CAGR of over 32% between FY23 and FY25, driven by demand from the pharma and agriculture sectors.
Profit After Tax (PAT):
There has been a massive surge in profitability, jumping from ₹0.82 Cr in FY23 to ₹4.48 Cr in FY25, indicating that the company is scaling efficiently.
EBITDA:
Operational efficiency is visible here; margins improved significantly to nearly 24% in FY25, likely due to the automation of their corrugated board plant.
Net Worth:
The steady increase in net worth reflects the company’s ability to retain earnings and reinvest in the business, strengthening its balance sheet.
Total Borrowing:
While debt levels have remained relatively flat around ₹18-19 Cr, the IPO objective to repay nearly ₹9 Cr will significantly reduce the finance cost burden moving forward.
Assets:
Asset growth has been consistent, largely driven by capex in plant and machinery, positioning the company for higher production capacity.
P/E Ratio and Peer Comparison
Based on its Fiscal Year 2025 earnings per share (EPS) of ₹14.21, the IPO is priced at a Price-to-Earnings (P/E) multiple of approximately 6.9x at the upper end of the price band (₹98).
P/E Ratio = ₹98 (Price) / ₹14.21 (Earnings Per Share)
P/E Ratio ≈ 6.9x
Peer Analysis Table:
| Company | P/E Ratio | RoNW (%) | Revenue CAGR (FY23-25) |
Phytochem Remedies | 6.9 | 34.07% | 32.46% |
| Perfectpac Ltd. | 20.49 | 8.40% | 6.55% |
| Worth Peripherals Ltd. | 14.43 | 9.10% | (4.32%) |
| G K P Printing & Packaging | 18.36 | 3.80% | (26.70%) |
Industry Average | 17.76 | - | - |
Analysis:
Phytochem Remedies' IPO is priced at a P/E ratio of 6.90. This is below the industry average of 17.76 and the ratios of its listed peers. The company also reports a Return on Net Worth (RoNW) of 34%, which is higher than the single-digit RoNW reported by many peers, alongside positive revenue growth.
Industry Outlook
Growth Potential:
The Indian packaging industry is often called the "silent salesman" of the economy. With the rise of e-commerce, organized retail, and the pharmaceutical boom in India, the demand for corrugated boxes is on a steady upward trajectory.
Market Trends:
There is a distinct shift toward sustainable packaging. Phytochem’s move to use IPO funds for manufacturing paper bags and oil-resistant paper aligns perfectly with the government’s push against single-use plastics. However, the market remains highly fragmented with stiff competition from unorganized local players.
What Are The Strengths and Risks of Phytochem Remedies IPO?
Strengths:
- Financial Health: The company boasts a high Return on Net Worth (34.07%) and strong revenue growth, outperforming many listed peers.
- Operational Efficiency: The shift to fully automatic plants has improved EBITDA margins significantly.
- Strategic Location: Situated in Jammu, the company enjoys logistical advantages for serving the Northern Indian markets, particularly the pharmaceutical hub in the region.
Risks:
- Geographic Concentration: This is a major risk factor—100% of the revenue comes from Jammu & Kashmir. Any political unrest or regional economic downturn could halt operations.
- Customer Concentration: The top 10 customers account for over 51% of revenue. Losing a key client could dent the balance sheet.
- Raw Material Volatility: The company does not have long-term agreements with suppliers (kraft paper, etc.), making it vulnerable to price fluctuations in the paper market.
Key Considerations for Investors
This section is for information purposes only and does not constitute financial advice.
The investment considerations for the Phytochem Remedies IPO include its below-industry-average P/E ratio and a minimum application size that requires a substantial capital outlay from retail investors. Unlike typical IPOs, the minimum retail application here is 2,400 shares (2 Lots), requiring an investment of over ₹2.35 Lakhs.
While the financials present a picture of a fast-growing, highly profitable company, the "eggs in one basket" risk regarding its location in Jammu and reliance on a few top clients is a reality.
The IPO proceeds utilized for debt reduction should technically boost the bottom line further by saving on interest costs. A key consideration for investors is evaluating the company's growth potential alongside the geographic concentration risks present in its operational profile
Disclaimer: This article is strictly for educational purposes. Please consult a SEBI-registered investment advisor before making any investment decisions.
Key Takeaways
- IPO Price: ₹98 per share (Fixed).
- Lot Size: 1200 shares (Minimum Retail Investment is ₹2,35,200 (2 Lots).
- Allotment Date: December 23, 2025.
- Listing: BSE SME platform on December 26, 2025.
FAQs on Phytochem Remedies IPO
What is Phytochem Remedies IPO GMP today?
The GMP is an unofficial market sentiment indicator that changes daily. Check our GMP hub for the latest updates.
What is Phytochem Remedies IPO price band?
The issue has a fixed price of ₹98 per equity share.
What is Phytochem Remedies IPO allotment date?
The basis of allotment is expected to be finalized on Tuesday, December 23, 2025.
How to check Phytochem Remedies IPO allotment status?
You can check the allotment status on the website of the Registrar (link to be updated once notified) or via the BSE website. You can also check the IPO allotment status through our ipo allotment status hub page.
What is Phytochem Remedies IPO listing date?
The shares are tentatively scheduled to list on the BSE SME platform on Friday, December 26, 2025.
Investment Perspective on Phytochem Remedies IPO
The company shows strong fundamentals with high RoNW and increasing margins. However, the high minimum investment ticket size and geographic concentration in J&K are factors that risk-averse investors should consider carefully.
Disclaimer:
The information provided in this article is based on the Red Herring Prospectus (RHP) and available public data. It is factual and neutral. IPO investments are subject to market risks. Read all scheme-related documents carefully. This is not a recommendation to buy or sell.
